We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current ALEC market cap is 402.15M. The company's latest EPS is USD -1.3618 and P/E is -3.19.
Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 14.44M | 16.55M | 56.21M | 9.11M | 15.19M |
Operating Income | -55.44M | -50.12M | -3.59M | -50.58M | -47.45M |
Net Income | -52.43M | -45.86M | 1.38M | -44.48M | -41.43M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 21.22M | 21.1M | 207.09M | 133.62M | 97.06M |
Operating Income | -114.4M | -195.17M | -37.36M | -137.83M | -151.74M |
Net Income | -105.39M | -190.23M | -36.33M | -133.31M | -130.39M |
Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 787.65M | 748.34M | 708.74M | 672.4M | 621.83M |
Total Liabilities | 573.21M | 565.33M | 512.43M | 509.84M | 487.67M |
Total Equity | 214.44M | 183.02M | 196.31M | 162.56M | 134.16M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 421.91M | 488.25M | 814.66M | 787.65M | 621.83M |
Total Liabilities | 227.17M | 220.72M | 513.93M | 573.21M | 487.67M |
Total Equity | 194.74M | 267.53M | 300.72M | 214.44M | 134.16M |
Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -20.33M | -48.55M | -91.55M | -138.09M | -184.16M |
Investing | -159.01M | 88.7M | 66.89M | 83.85M | 101.92M |
Financing | 4.51M | 1.08M | 1.96M | 1.96M | 2.55M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -99.31M | -166.73M | 298.55M | -20.33M | -184.16M |
Investing | -48.87M | -105.05M | -49.66M | -159.01M | 101.92M |
Financing | 172.35M | 232.11M | 30.3M | 4.51M | 2.55M |
Market Cap | 402.15M |
Price to Earnings Ratio | -3.19 |
Price to Sales Ratio | 4.29 |
Price to Cash Ratio | 5.59 |
Price to Book Ratio | 3.1 |
Dividend Yield | - |
Shares Outstanding | 95.75M |
Average Volume (1 week) | 1.06M |
Average Volume (1 Month) | 669.84k |
52 Week Change | -43.47% |
52 Week High | 9.065 |
52 Week Low | 3.66 |
Spread (Intraday) | 2.82 (40.17%) |
Company Name | Alector Inc |
Address |
1209 orange street wilmington, delaware 19801 |
Website | https://www.alector.com |
Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions